Associating liver partition and portal vein ligation or combined transarterial chemo-embolisation and portal vein embolisation for staged hepatectomy for HBV-related hepatocellular carcinoma  

作　　者：Paschalis Gavriilidis Timothy M.Pawlik Tomer Meirson Daniel Azoulay 

机构地区：[1]Department of Surgery,Colchester General Hospital,Colchester,UK [2]Department of Surgery,The Ohio State University Wexner Medical Center,James Comprehensive Cancer Center,Columbus,OH,USA [3]Davidoff Cancer Center,Rabin Medical Center-Bellinson Hospital,Petah Tikya,Israel [4]Department of Hepato-Biliary and Liver Transplantation Surgery,Paul Brousse University Hospital,Paris-Saclay University,Villejuif,France

出　　处：《Hepatobiliary Surgery and Nutrition》2023年第2期272-275,共4页肝胆外科与营养（英文）

摘　　要：Many patients with hepatocellular carcinoma are diagnosed with large tumours at an advanced stage.In addition,conditions such as liver fibrosis,cirrhosis,portal hypertension,viral load,and portal vein thrombosis due to either non-neoplastic or portal vein tumour thrombus limit the indications for surgical management to a select subset of individuals(1).

关 键 词：Associating liver partition and portal vein ligation(ALPPS) transarterial chemoembolization(TACE) portal vein embolisation(PVE) 

分 类 号：R657.3[医药卫生—外科学]